A multiscale hybrid approach for vasculogenesis and related potential blocking therapies

Marco Scianna1, Luca Munaron, Luigi Preziosi

  • 1Department Of Mathematics, Politecnico Di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.

Insights

This study presents a hybrid model of tumor angiogenesis, linking subcellular signaling to cell behavior. The model validates existing cancer therapies and suggests novel, counter-intuitive treatment strategies.

Area of Science:

  • Computational Biology
  • Cancer Research
  • Biophysics

Background:

  • Solid tumors require angiogenesis for growth and metastasis.
  • Targeting malignant angiogenesis is a key cancer treatment strategy.
  • Existing in vitro and in silico models have limitations in capturing complex biological interactions.

Purpose of the Study:

  • To develop a hybrid individual cell-based model integrating biochemical events with cellular dynamics.
  • To link subcellular mechanisms, like VEGF signaling and calcium pathways, to macroscopic cell behaviors.
  • To evaluate current and propose novel therapeutic interventions for malignant angiogenesis.

Main Methods:

  • A hybrid model combining continuous extracellular modeling (VEGF), extended Cellular Potts Model (CPM) for cell dynamics, and reaction-diffusion equations for intracellular pathways (calcium signaling).
  • Modeling spans extracellular, cellular, and subcellular biological levels.
  • Analysis focused on the interplay between VEGF, calcium dynamics, and cell behavior.

Main Results:

  • The model accurately reflects the known interactions between calcium signals and VEGF dynamics in malignant vasculogenesis.
  • It confirms the efficacy of established pharmacological interventions.
  • It identifies potentially effective, novel therapeutic approaches.

Conclusions:

  • The hybrid model effectively bridges subcellular biochemical processes with emergent cellular behaviors in angiogenesis.
  • The findings support the use of integrated modeling for understanding cancer biology and drug development.
  • The study proposes new, potentially counter-intuitive therapeutic strategies targeting tumor angiogenesis.